tirzepatide approval date GLP-1 Medications for Weight Loss: Semaglutide vs vs Retat – Revolution Health & Wellness TrimRX | Semaglutide vs Tirzepatide:

, Mukherjee, S

Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected

The 2 major incretins found in the body are gastric-inhibitory-polypeptide (GIP) and glucagon-like-peptide-1 (GLP-1) [2]

Each capsule contains 500mcg of BPC-157 and 500mcg of TB-500, for a total standardized research peptide blend of 1000mcg per capsule

Notably, though, there was a decreased chance of suicide attempts and completed suicides for patients taking liraglutide and semaglutide